• Mashup Score: 46
    TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events - 7 day(s) ago

    Despite optimization with lifestyle modifications and medications, complications of coronary artery disease (CAD) remain the leading cause of adult mortality worldwide. This study aimed to identify proteins and pathways linked to recurrent CAD events to better understand residual risk. We used data from 1,009 participants in the UK Biobank (UKB) with baseline Olink plasma proteomic measures and CAD. Among 1,463 proteins tested, 102 proteins were independently associated with recurrent CAD events. Molecular functions were significantly enriched for tumor necrosis factor receptor (TNFR) activity by 100-fold (p-value = 6.37×10-10). Of the 16 proteins related to TNF annotated by Gene Ontology, TNF-alpha, TNFR1, and TNFR2 were all significantly associated with increased risk of recurrent CAD events. While TNFR1 and TNFR2 were initially thought to have opposing roles in cardiac remodeling post-MI, this study highlights the complex interaction between these pathways and the need to identify s

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of pnatarajanmd
      pnatarajanmd

      Our preprint proteomic study led by @ImJiwooLee @mit_hst @harvardmed student & @BellomoTiffany @MGHVascular resident strongly implicates the TNFR pathway in recurrent CAD events despite current medical & procedural therapies https://t.co/XU7WjQgC15 @medrxivpreprint @JHalfordMD https://t.co/DcX5r9FD1q

  • Mashup Score: 0
    Genetic risk effects on psychiatric disorders act in sets - 18 day(s) ago

    Genetic studies of psychiatric disorders have typically assumed that all genetic effects contribute additively to disease liability. However, it is likely that psychiatric disorders have unrecognized subtypes, where synergistic sets of risk variants co-occur within certain cases more than expected under additivity. The existence of synergistic sets induces a structured form of statistical interactions called coordinated epistasis. We test for these interactions in five psychiatric disorders and find evidence for synergistic sets, and by extension, disorder subtypes. We further find that synergistic sets contributing to comorbidities are mostly disorder-specific, despite high genetic correlations between disorders, supporting current diagnostic distinctions between disorders. Finally, we find that genetic risk factors shared across disorders identify a cross-disorder subtype that is likely the result of heritable confounders, rather than disorder-specific etiology. Our results show that

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of pash22
      pash22

      Genetic risk effects on psychiatric disorders act in sets https://t.co/59IVFhkU4i via @jonathan_flint1

  • Mashup Score: 26
    Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida - 23 day(s) ago

    Comparative effects of the mRNA COVID-19 vaccines on mortality and other health outcomes are uncertain. Matched cohort analysis of 1,962,822 adults living in Florida who received a first dose of either BNT162b2 (Pfizer) or mRNA-1273 (Moderna) between December 18, 2020, and August 31, 2021, was used to examine 12-month risk of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality. Matching was performed on seven criteria, including census tract. Compared with mRNA-1273 recipients, BNT162b2 recipients had significantly higher risk for all-cause mortality (783.6 vs. 562.4 deaths per 100,000; odds ratio, OR [95% CI]: 1.407 [1.358, 1.457]), cardiovascular mortality, COVID-19 mortality and non-COVID-19 mortality. Negative control outcomes and robustness analyses did not show any indication of meaningful unobserved residual confounding that is likely to alter the results. The results of this study are consistent with cumulative evidence from prior literature showing worse outcomes i

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
  • Mashup Score: 41
    Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms - 28 day(s) ago

    Purpose Delta-like ligand 3 (DLL3) is an emerging target across neuroendocrine cancers, but remains underexplored in gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) including poorly differentiated neuroendocrine carcinomas (GEP NECs) and well differentiated neuroendocrine tumors (NETs). We aimed to define the landscape of DLL3 expression and feasibility of DLL3-targeted imaging in this population. Patients and Methods We completed DLL3 immunohistochemistry (IHC) on 360 tumor samples from patients with GEP NENs, analyzing associations between DLL3 IHC positivity and clinicopathologic features and outcomes. [89Zr]Zr-DFO-SC16.56 DLL3 immunoPET-CT imaging was performed in six patients with DLL3 IHC-positive advanced GEP NENs as part of a phase II clinical trial. Results Among GEP NECs, DLL3 expression was identified in 53/75 (71%) samples, was enriched for small cell histology, and did not demonstrate prognostic significance. Among well differentiated pancreatic NETs (PanNETs),

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of OncoThor
      OncoThor

      On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in 71% of GEPNECs and 43% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out! @lisabodei @DianeReidyLagun @natasharekhtman https://t.co/IcmzzZBrU8

  • Mashup Score: 7
    Automation of Systematic Reviews with Large Language Models - 2 month(s) ago

    Systematic reviews (SRs) inform evidence-based decision making. Yet, they take over a year to complete, are prone to human error, and face challenges with reproducibility; limiting access to timely and reliable information. We developed otto-SR, an end-to-end agentic workflow using large language models (LLMs) to support and automate the SR workflow from initial search to analysis. We found that otto-SR outperformed traditional dual human workflows in SR screening (otto-SR: 96.7% sensitivity, 97.9% specificity; human: 81.7% sensitivity, 98.1% specificity) and data extraction (otto-SR: 93.1% accuracy; human: 79.7% accuracy). Using otto-SR, we reproduced and updated an entire issue of Cochrane reviews (n=12) in two days, representing approximately 12 work-years of traditional systematic review work. Across Cochrane reviews, otto-SR incorrectly excluded a median of 0 studies (IQR 0 to 0.25), and found a median of 2.0 (IQR 1 to 6.5) eligible studies likely missed by the original authors. M

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of pash22
      pash22

      Automation of Systematic Reviews with Large Language Models https://t.co/0ZtCGa8MIT via @nikbobrovitz et al https://t.co/alszSQ1ENO

  • Mashup Score: 8
    Genome-wide meta-analysis identifies genetic risk factors and implicates multiple body systems in panic attacks and disorder - 2 month(s) ago

    Panic attacks, sudden episodes of intense fear accompanied by physical and psychological symptoms, affect approximately 23% of the population. Panic disorder, diagnosed in 2 to 4%, involves recurrent attacks followed by persistent worry about further attacks, leading to functional impairment and avoidance behaviours. We conducted genome-wide association meta-analyses of panic attacks and panic disorder (61,746 and 29,775 cases, respectively, and 105,814 controls), identifying the first genome-wide significant variants for both traits (16 for panic attacks; 7 for panic disorder). Geneset analysis using single-cell RNA sequencing data implicated afferent neurons from the eye, heart, and lung in panic attacks, suggesting a critical role for sensory processing and interoceptive awareness. Further analyses suggested that these associations generalize to other psychiatric disorders. These findings offer novel insights into the biological mechanisms underlying panic, the role of afferent neur

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of pash22
      pash22

      Genome-wide meta-analysis identifies genetic risk factors and implicates multiple body systems in panic attacks and disorder https://t.co/toS36rrP9b via @psychgenomics et al https://t.co/BbtHAKugEu

  • Mashup Score: 3
    Convalescent plasma treatment of B-cell depleted patients with COVID-19: systematic review and individual participant data meta-analysis - 2 month(s) ago

    Background COVID-19 convalescent plasma (CCP) is obtained from people recently recovered from COVID-19 and contains viral-neutralizing antibodies. Because such treatment is safe and effective against SARS-CoV-2, the US Food and Drug Administration (FDA) has recently authorized the use of CCP for COVID-19 patients with immunodeficiencies. Currently available CCP is a “hybrid” product with antibodies from individuals who had both infection and vaccination (vaccine-boosted CCP). In this context, there is growing interest in CCP treatment outcomes in specific groups of immunocompromised patients. Specifically, B-cell depleted patients are at risk of not producing antibodies after either infection or vaccination. Hence, B-cell depleted patients are conceivably among those who would benefit the most from CCP. We thus conducted a systematic review and individual patient data meta-analysis to assess characteristics associated with 60-day survival in B-cell depleted patients transfused with CCP

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Convalescent plasma treatment of B-cell depleted patients with COVID-19: systematic review and individual participant data meta-analysis {pre-print} [May 27, 2025] @ZarembaSolomiia et al. @DrMJoyner @medrxivpreprint https://t.co/W3R0EeQVS9 #COVID19CP #COVID19

  • Mashup Score: 96
    Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida - 2 month(s) ago

    Objective: To examine the relative impact of the initial series of the messenger RNA (mRNA) BNT162b2 (Pfizer) and mRNA-1273 (Moderna) on all-cause and non-COVID-19 mortality among Florida residents. Design: Matched cohort with cumulative and adjusted assessments of risk over 12 month follow up. Setting: Florida’s state-level public health databases with records about COVID-19 vaccination, sociodemographic characteristics of vaccine recipients, location of vaccination, and vital statistics. Participants: Matched cohort of 1,470,100 noninstitutionalized adult Florida residents receiving at least two doses, less than six weeks apart, of either the BNT162b2 or mRNA-1273 mRNA vaccine between December 18, 2020, and August 31, 2021. Intervention: Initial vaccination with two doses of either BNT162b2 or mRNA-1273 Main outcome measures: All-cause, cardiovascular, COVID-19, and non-COVID-19 mortality within 12 months after the second COVID-19 vaccine dose Results: There were 9,162,484 noninstitu

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of DrFerdowsi
      DrFerdowsi

      RT @RetsefL: Link: https://t.co/0E2RWXj1Vy

  • Mashup Score: 7
    Automation of Systematic Reviews with Large Language Models - 2 month(s) ago

    Systematic reviews (SRs) inform evidence-based decision making. Yet, they take over a year to complete, are prone to human error, and face challenges with reproducibility; limiting access to timely and reliable information. We developed otto-SR, an end-to-end agentic workflow using large language models (LLMs) to support and automate the SR workflow from initial search to analysis. We found that otto-SR outperformed traditional dual human workflows in SR screening (otto-SR: 96.7% sensitivity, 97.9% specificity; human: 81.7% sensitivity, 98.1% specificity) and data extraction (otto-SR: 93.1% accuracy; human: 79.7% accuracy). Using otto-SR, we reproduced and updated an entire issue of Cochrane reviews (n=12) in two days, representing approximately 12 work-years of traditional systematic review work. Across Cochrane reviews, otto-SR incorrectly excluded a median of 0 studies (IQR 0 to 0.25), and found a median of 2.0 (IQR 1 to 6.5) eligible studies likely missed by the original authors. M

    Source: www.medrxiv.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of pash22
      pash22

      Automation of Systematic Reviews with Large Language Models https://t.co/0ZtCGa8MIT via @nikbobrovitz et al https://t.co/alszSQ1ENO

Load More